Yield of Opportunistic Targeted Screening for Type 2 Diabetes in Primary Care: The Diabscreen Study

PURPOSE In screening for type 2 diabetes, guidelines recommend targeting high-risk individuals. Our objectives were to assess the yield of opportunistic targeted screening for type 2 diabetes in primary care and to assess the diagnostic value of various risk factors. METHODS In 11 family practices (total practice population = 49,229) in The Netherlands, we conducted a stepwise opportunistic screening program among patients aged 45 to 75 years by (1) identifying high-risk individuals (=1 diabetes risk factor) and low-risk individuals using the electronic medical record, (2) obtaining a capillary fasting plasma glucose measurement, repeated on a separate day if the value was greater than 110 mg/dL, and (3) obtaining a venous sample if both capillary fasting plasma glucose values were greater than 110 mg/dL and at least 1 sample was 126 mg/dL or greater. We calculated the yield (percentage of invited patients with undiagnosed diabetes), number needed to screen (NNS), and diagnostic value of the risk factors (odds ratio and area under the receiver operating characteristic curve). RESULTS We invited for a first capillary measurement 3,724 high-risk patients seen during usual care and a random sample of 465 low-risk patients contacted by mail. The response rate was 90% and 86%, respectively. Ultimately, 101 high-risk patients (2.7%; 95% confidence interval [CI], 2.2%–3.3%; NNS = 37) and 2 low-risk patients (0.4%; 95% CI, 0.1%–1.6%; NNS = 233) had undiagnosed diabetes (P <.01). The prevalence of diabetes among patients 45 to 75 years old increased from 6.1% to 6.8% as a result. Among diagnostic models containing various risk factors, a model containing obesity alone was the best predictor of undiagnosed diabetes (odds ratio = 3.2; 95% CI, 2.0–5.2; area under the curve=0.63). CONCLUSIONS The yield of opportunistic targeted screening was fair; obesity alone was the best predictor of undiagnosed diabetes. Opportunistic screening for type 2 diabetes in primary care could target middle-aged and older adults with obesity.

[1]  N. Wareham,et al.  How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort , 2012, Diabetologia.

[2]  R. Moss‐Morris,et al.  Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[3]  Kamlesh Khunti,et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.

[4]  Joan K. Morris,et al.  Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age , 2011, BDJ.

[5]  S. McGilloway,et al.  Psychological family intervention for poorly controlled type 2 diabetes. , 2011, The American journal of managed care.

[6]  E. Broadbent,et al.  Illness and Treatment Perceptions Are Associated With Adherence to Medications, Diet, and Exercise in Diabetic Patients , 2011, Diabetes Care.

[7]  The Emerging Risk Factors Collaboration.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[8]  Justin Feigelman,et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.

[9]  Jiang He,et al.  Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes , 2009, Annals of Internal Medicine.

[10]  V L Lawson,et al.  The importance of health belief models in determining self‐care behaviour in diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[11]  S. Griffin,et al.  How much might cardiovascular disease risk be reduced by intensive therapy in people with screen‐detected diabetes? , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[12]  D. Kansagara,et al.  Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[13]  B. Yawn,et al.  Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[14]  Stephen W. Sorensen,et al.  Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults , 2008, Diabetes Care.

[15]  Silvio E. Inzucchi,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[16]  Nicola J Cooper,et al.  Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis , 2008, BMJ : British Medical Journal.

[17]  J. Harvey,et al.  The development of personal models of diabetes in the first 2 years after diagnosis: a prospective longitudinal study , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[18]  J. Bottomley,et al.  Economic costs of diabetes in the US in 2007 — Implications for Europe , 2008 .

[19]  B. Devellis,et al.  Effect of couple illness perception congruence on psychological adjustment in women with rheumatoid arthritis. , 2008, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[20]  Thodoris D. Karapantsios,et al.  Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007. , 2008, Diabetes Care.

[21]  B. Arroll,et al.  Screening for diabetes and prediabetes , 2007, The Lancet.

[22]  C. van Weel,et al.  Screening for type 2 diabetes in primary care using a stepwise protocol: the Diabscreen study. , 2007, Primary care diabetes.

[23]  R. Stolk,et al.  Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. , 2007, Family practice.

[24]  A. Searle,et al.  Illness representations among patients with type 2 diabetes and their partners: relationships with self-management behaviors. , 2007, Journal of psychosomatic research.

[25]  S. M. Smith,et al.  Living with Type 2 diabetes: a family perspective , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[26]  S. McGilloway,et al.  Changing illness perceptions in patients with poorly controlled type 2 diabetes, a randomised controlled trial of a family-based intervention: protocol and pilot study , 2007, BMC family practice.

[27]  C. van Weel,et al.  Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record. , 2007, Family practice.

[28]  G. Rutten,et al.  [Summary of the practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners]. , 2006, Nederlands tijdschrift voor geneeskunde.

[29]  D. D. de Ridder,et al.  Psychological Outcomes of Patients With Screen-Detected Type 2 Diabetes , 2006, Diabetes Care.

[30]  Elizabeth Broadbent,et al.  The brief illness perception questionnaire. , 2006, Journal of psychosomatic research.

[31]  D. D. de Ridder,et al.  Is spousal support always helpful to patients with asthma or diabetes? A prospective study , 2005 .

[32]  C. van Weel,et al.  Longitudinal Research and Data Collection in Primary Care , 2005, The Annals of Family Medicine.

[33]  J. Weinman,et al.  Illness perceptions in coronary heart disease. Sociodemographic, illness-related, and psychosocial correlates. , 2005, Journal of psychosomatic research.

[34]  L. Bouter,et al.  Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study , 2004, Journal of internal medicine.

[35]  G. Nijpels,et al.  No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[36]  Peter Croft,et al.  Quality of morbidity coding in general practice computerized medical records: a systematic review. , 2004, Family practice.

[37]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[38]  D. Fleming,et al.  The prevalence of known diabetes in eight European countries. , 2004, European journal of public health.

[39]  A. Hattersley,et al.  A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care. , 2004, Family practice.

[40]  S. Colagiuri,et al.  Comparability of venous and capillary glucose measurements in blood , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[41]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[42]  S. Smith,et al.  Irish diabetes detection programme in general practice , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[43]  L. Bouter,et al.  Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. , 2003, Diabetes care.

[44]  Russell Harris,et al.  Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[45]  U. P. S. T. Force,et al.  Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale , 2003, Annals of Internal Medicine.

[46]  T. Bodenheimer,et al.  Patient self-management of chronic disease in primary care. , 2002, JAMA.

[47]  A. Robinson,et al.  Screening for diabetes in general practice: cross sectional population study , 2001, BMJ : British Medical Journal.

[48]  G. van der Wal,et al.  Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. , 2001, Diabetes care.

[49]  Nicholas J Wareham,et al.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria , 2001, BMJ : British Medical Journal.

[50]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[51]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[52]  C. Weel,et al.  Cardiovascular Morbidity and Mortality in Type 2 Diabetic Patients: a 22‐year Historical Cohort Study in Dutch General Practice , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[53]  M. Harris,et al.  Frequency and Determinants of Screening for Diabetes in the U.S , 1994, Diabetes Care.

[54]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[55]  J. Knottnerus,et al.  Computerized health information in The Netherlands: a registration network of family practices. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.

[56]  C. D. A. Stehouwer,et al.  The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes , 2010, Diabetologia.

[57]  J. Johnson,et al.  Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials , 2010, Diabetologia.

[58]  C. van Weel.  The Continuous Morbidity Registration Nijmegen: background and history of a Dutch general practice database. , 2008, The European journal of general practice.

[59]  A. Brennan,et al.  Screening for type 2 diabetes: literature review and economic modelling. , 2007, Health technology assessment.

[60]  G. Rutten,et al.  Screening for Type 2 Diabetes , 2003 .

[61]  C. van Weel,et al.  Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. , 2002, The Journal of family practice.

[62]  Yael Benyamini,et al.  Illness representations: Theoretical foundations. , 1997 .

[63]  B. Bentsen.  International classification of primary care. , 1986, Scandinavian journal of primary health care.